{"eightKs": [{"content": "Entry into a Material Definitive Agreement. On May 5, 2020, Cyanotech Corporation (the \u201cCompany\u201d), received the proceeds of a loan (the \u201cLoan\u201d) from First Hawaiian Bank (the \u201cLender\u201d) in the principal amount of $1.38 million pursuant to the Paycheck Protection Program (the \u201cPPP\u201d) under the Coronavirus Aid, Relief, and Economic Security Act (the \u201cCARES Act\u201d), which was enacted March 27, 2020. The Loan is evidenced by a promissory note (a \u201cNote\u201d), dated April 30, 2020 issued by the Company to the Lender. The Note matures on May 5, 2022 and bears interest at a rate of 1.00% per annum, payable monthly commencing on November 5, 2020, following an initial deferral period as specified under the PPP. The Note may be prepaid by the Company at any time prior to maturity with no prepayment penalties. Proceeds from the Loan will be available to the Company to fund designated expenses, including certain payroll costs, group health care benefits and other permitted expenses, ", "date": "2020-05-11", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774920010307/cyan20200508_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": "Submission of Matters to a Vote of Security Holders. On August 27, 2020, the Company held its 2020 Annual Meeting of the Stockholders (the \u201cAnnual Meeting\u201d). The Stockholders re-elected the Board of Directors and approved the proposal listed below. The final results for the votes regarding each item or proposal are set forth below. The proposals are described in detail in the Company\u2019s proxy statement filed with the Securities and Exchange Commission on July 15, 2020. 1. To elect six directors among the nominees named in the proxy statement. Name  Votes For  Votes Withheld  Broker Non-Votes Gerald R. Cysewski  2,533,058  1,162,940  1,022,007 Michael A. Davis  2,230,711  1,465,287  1,022,007 Nancy E. Katz  2,277,079  1,418,919  1,022,007 Walter B. Menzel  2,325,967  1,370,031  1,022,007 David M. Mulder  2,273,741  1,422,257  1,022,007 David L. Vied  2,259,604  1,436,394  1,022,007 2. To ratify the selection of Grant Thornton LLP as the Company\u2019s independent registered public acc", "date": "2020-08-31", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774920018975/cyan20200828_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": " Entry into a Material Definitive Agreement. On April 12, 2019, Cyanotech Corporation (the \u201cCompany\u201d) obtained an unsecured subordinated loan from Skywords Family Foundation, Inc. (\u201cSkywords\u201d) in the principal amount of $1,500,000 pursuant to a Promissory Note (the \u201cNote\u201d) executed by the Company in favor of Skywords. Skywords is controlled by Michael Davis, the Company\u2019s Chairman of the Board of Directors and largest stockholder. The Note bears interest at a rate of 1% plus the prime rate (as published by the Wall Street Journal), which will be recalculated and payable on a quarterly basis. The principal amount and any accrued and unpaid interest will be due and payable on April 12, 2021, unless accelerated in an event of default. The Company may prepay the Note at any time without penalty. The proceeds of the Note will be used to pay down accounts payable and for general operating capital purposes. The financing was undertaken to address a decrease in cash and cash equi", "date": "2019-04-12", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774919007116/cyan20190411_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": "Entry into a Material Definitive Agreement. The disclosure in Item 5.02 is incorporated by reference herein. Item 1.02. Termination of a Material Definitive Agreement. The disclosure in Item 5.02 is incorporated by reference herein. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, Mawae Morton tendered his resignation as Chief Executive Officer and as a director of Cyanotech Corporation (the \u201cCompany\u201d) and its subsidiary on April 22, 2019. The resignation notice stated that Mr. Morton\u2019s resignation as Chief Executive Officer would become effective as of May 22, 2019 (the \u201cSeparation Date\u201d). On June 3, 2019, the Company and Mr. Morton entered into Separation Agreement (the \u201cSeparation Agreement\u201d), pursuant to which, in exchange for granting the Company a release of certain claims, agreeing to comply with certain restrictive covenants, and ag", "date": "2019-06-07", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774919011624/cyan20190606g_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": "Submission of Matters to a Vote of Security Holders. On August 22, 2019, the Company held its 2019 Annual Meeting of the Stockholders (the \u201cAnnual Meeting\u201d). The Stockholders re-elected the Board of Directors and approved the proposals listed below. The final results for the votes regarding each item or proposal are set forth below. The proposals are described in detail in the Company\u2019s proxy statement filed with the Securities and Exchange Commission on July 10, 2019. 1. To elect six directors among the nominees named in the proxy statement. Name  Votes For  Votes Withheld  Broker Non-Votes Gerald R. Cysewski  2,824,685  1,094,308  1,616,159 Michael A. Davis  2,782,232  1,136,761  1,616,159 Nancy E. Katz  2,806,514  1,112,479  1,616,159 Walter B. Menzel  2,806,206  1,112,787  1,616,159 David M. Mulder  2,806,614  1,112,379  1,616,159 David L. Vied  2,812,219  1,106,774  1,616,159 2. To approve, on an advisory basis, the compensation of the Company\u2019s Named Executive Officers. V", "date": "2019-08-27", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774919017475/cyan20190823_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On September 28, 2020, Cyanotech Corporation, a Nevada corporation (the \u201cCompany\u201d), named Felicia Ladin as its Chief Financial Officer (\u201cCFO\u201d), Vice President (\u201cVP\u201d) of Finance and Administration, and Treasurer. In connection with the foregoing appointment, on September 25, 2020, Brian Orlopp resigned and entered into a Separation Agreement (the \u201cSeparation Agreement\u201d) with the Company pursuant to which he will receive severance payments equal to two months of his then current base salary, payments representing additional monthly housing and travel allowance and payments of premiums for continuing health coverage for two months in exchange for, among other matters, a general release of claims in favor of the Company and its affiliates and an agreement to not solicit any employee of the Company to leave their employment at the ", "date": "2020-10-01", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774920020587/cyan20200930_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}, {"content": "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.  On April 22, 2019, Mawae Morton resigned as Chief Executive Officer and as a director of Cyanotech Corporation (the \u201cCompany\u201d) and its subsidiary. Mr. Morton\u2019s resignation as Chief Executive Officer will be effective as of May 22, 2019; his resignation as a director became effective immediately. Concurrently with the Mr. Morton\u2019s resignation as a director of the Company, the Board of Directors reduced the size of the Board from seven directors to six directors. As a result, there is currently no vacancy on the Board of Directors.  Effective April 22, 2019, the Company named its founder, Gerald R. Cysewski, Ph.D., as its President. Mr. Cysewski, who currently serves as the Company\u2019s Executive Vice President and Chief Scientific Officer, will not receive any additional compensation for serving as the Company\u2019s President. Mr. Cysew", "date": "2019-04-26", "details": "", "filingType": "8-K", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774919008075/cyan20190425_8k.htm", "nonComplianceType": "", "nonCompliant": false, "tags": []}], "importantItems": [], "na": false, "ownership": {"calculatedFloat": 0, "date": "", "footnotes": null, "rows": null, "sharesOutstanding": 0, "source": "", "sourceType": "", "sumActual": 0, "textbookFloat": 0}, "shelfs": null, "stockInfo": {"exchange": "NASDAQ", "float": "3.61M", "income": "1.20M", "io": "25.40%", "marketCap": "19.59M", "name": "Cyanotech Corporation", "news": [{"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-third-130000468.html", "date": "Feb-11-21 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-second-130000616.html", "date": "Nov-12-20 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2021"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-corporation-launches-bioastin-120000964.html", "date": "Oct-01-20 ", "source": "Business Wire", "text": "Cyanotech\u00ae Corporation Launches BioAstin\u00ae"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-first-120000900.html", "date": "Aug-11-20 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the First Quarter of Fiscal 2021"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-corporation-welcomes-charles-j-130000307.html", "date": "Jul-23-20 ", "source": "Business Wire", "text": "Cyanotech\u00ae Corporation Welcomes Charles J. Hartmann as Senior Sales and Marketing Director"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-fourth-120000361.html", "date": "Jun-23-20 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2020"}, {"anchor": "https://finance.yahoo.com/news/nutrex-hawaii-announces-awareness-program-191800586.html", "date": "Jun-18-20 ", "source": "Business Wire", "text": "Nutrex Hawaii\u00ae Announces Awareness Program to Inform and Educate Consumers About Their Farm Grown Products"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-donates-protein-powder-medical-180000416.html", "date": "Apr-11-20 ", "source": "Business Wire", "text": "Cyanotech\u00ae Donates Protein Powder and Medical Supplies to Local Hospitals"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-third-130000146.html", "date": "Feb-11-20 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-second-130000843.html", "date": "Nov-12-19 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-first-120000649.html", "date": "Aug-13-19 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the First Quarter of Fiscal 2020"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-fourth-120000683.html", "date": "Jul-01-19 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2019"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-third-130000380.html", "date": "Feb-13-19 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2019"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-names-brian-orlopp-vp-130000599.html", "date": "Jan-09-19 ", "source": "Business Wire", "text": "Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-second-130000320.html", "date": "Nov-12-18 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2019"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-corporation-signs-asset-purchase-170000111.html", "date": "Sep-07-18 ", "source": "Business Wire", "text": "Cyanotech\u00ae Corporation Signs Asset Purchase Agreement for Cellanas Kona Demonstration Facility"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-first-120000166.html", "date": "Aug-13-18 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019"}, {"anchor": "https://finance.yahoo.com/news/cyanotech-reports-financial-results-fourth-120000774.html", "date": "Jun-15-18 ", "source": "Business Wire", "text": "Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018"}], "price": "3.17", "profile": "Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, and direct to consumers, as well as in bulk form to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.", "sectorsAndCountry": "Consumer Defensive | Packaged Foods | USA", "sharesOutstanding": "6.10M", "shortOfFloat": "0.06%", "sixtyDayVWAP": 4.12, "symbol": "CYAN", "url": "https://finviz.com/quote.ashx?t=CYAN"}, "tenQ": {"filingType": "10-Q", "iXBRL": false, "stats": {"balanceSheetHTML": "", "balanceSheetUrl": "https://www.sec.gov/Archives/edgar/data/768408/000143774921002584/R2.htm", "cash": "3.3M", "cashBurnMonthly": "N/A", "cashFlowHTML": "", "cashFlowUrl": "https://www.sec.gov/Archives/edgar/data/768408/000143774921002584/R6.htm", "cashLeft": "N/A", "cashUsed": "N/A", "currentRatio": 2.26, "date": "Dec. 31, 2020", "isNegative": false, "monthsOfCash": "N/A", "na": false, "netCashOperating": "204.0k", "quickRatio": 0.5, "sharesOutstanding": "", "totalCurrentAssets": "15.0M", "totalCurrentLiabilities": "6.6M"}, "tenQDocument": {"content": "", "conversionPrices": null, "lagcT": "Liquidity and Capital Resources", "link": "https://www.sec.gov//Archives/edgar/data/768408/000143774921002584/cyan20201231_10q.htm", "liquidityAndGoingConcern": "As of December 31, 2020, the Company had cash of $3,322,000 and working capital of $8,364,000 compared to $2,417,000 and $8,369,000, respectively, at March 31, 2020. The Company has a Revolving Credit Agreement (\u201cCredit Agreement\u201d) with First Foundation Bank (\u201cBank\u201d) that allows the Company to borrow up to $2,000,000 on a revolving basis. At December 31, 2020 and March 31, 2020, the Company had outstanding borrowings of $1,750,000 and $2,000,000, respectively, on the line of credit. The line of credit is subject to renewal on August 30, 2021 and the Company intends to renew or replace it with another line of credit on or before the expiration date.  As of December 31, 2020, the Company had $4,777,000 in long-term debt (\u201cTerm Loans\u201d) payable to the Bank that require the payment of principal and interest monthly through August 2032. Pursuant to the Term Loans and the Credit Agreement, the Company is subject to annual financial covenants, customary affirmative and negative covenants and certain subjective acceleration clauses. As of March 31, 2019, the Company\u2019s debt service coverage ratio of -0.66:1 fell short of the Bank's annual requirement of 1.25:1. Additionally, on March 31, 2019, the Company\u2019s current ratio of 1.49:1 fell short of the Bank\u2019s annual requirement of 1.50:1. On June 17, 2019, the Bank provided the Company with a letter waiving the covenant violations as of March 31, 2019, but noting that the Bank reserved its rights to declare a default in the future if any covenants remain out of compliance at applicable measurement dates. As of March 31, 2020, the Company was in compliance with all required annual financial covenants under the Term Loans and the Credit Agreement.  In response to the coronavirus (\u201cCOVID-19\u201d) pandemic and the uncertainty surrounding the pandemic, in May 2020, the Company obtained a Paycheck Protection Program (\ufffd\ufffd... (See filing for more info)"}}, "ticker": "CYAN", "timelines": {"float": [], "os": [{"amount": 6097073, "date": "Dec. 31, 2020", "filingType": "10-Q", "sourceID": "", "sourceLink": "https://www.sec.gov//Archives/edgar/data/768408/000143774921002584/cyan20201231_10q.htm", "tag": ""}]}}